Report Detail
Global Cryptococcosis Market Insights, Forecast to 2025
- RnM3522854 |
- 14 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Cryptococcosis, also known as cryptococcal disease, is a potentially fatal fungal disease. It is caused by one of two species; Cryptococcus neoformans and Cryptococcus gattii
The global Cryptococcosis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cryptococcosis market based on company, product type, end user and key regions.
This report studies the global market size of Cryptococcosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cryptococcosis in these regions.
This research report categorizes the global Cryptococcosis market by top players/brands, region, type and end user. This report also studies the global Cryptococcosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bristol-Myers Squibb
Johnson & Johnson
Abbott
Novartis
Pfizer
Valeant Pharmaceuticals
Glenmark
Viamet Pharmaceuticals
Sigmapharm
Market size by Product
Amphotericin B (Amphocin and Fungizone)
Flucytosine (Ancobon)
Fluconazole (Diflucan)
Voriconazole
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Drug Store
Mail Order Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cryptococcosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cryptococcosis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cryptococcosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cryptococcosis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cryptococcosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cryptococcosis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cryptococcosis Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cryptococcosis Market Size Growth Rate by Product
- 1.4.2 Amphotericin B (Amphocin and Fungizone)
- 1.4.3 Flucytosine (Ancobon)
- 1.4.4 Fluconazole (Diflucan)
- 1.4.5 Voriconazole
- 1.5 Market by End User
- 1.5.1 Global Cryptococcosis Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Drug Store
- 1.5.5 Mail Order Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cryptococcosis Market Size
- 2.1.1 Global Cryptococcosis Revenue 2014-2025
- 2.1.2 Global Cryptococcosis Sales 2014-2025
- 2.2 Cryptococcosis Growth Rate by Regions
- 2.2.1 Global Cryptococcosis Sales by Regions
- 2.2.2 Global Cryptococcosis Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cryptococcosis Sales by Manufacturers
- 3.1.1 Cryptococcosis Sales by Manufacturers
- 3.1.2 Cryptococcosis Sales Market Share by Manufacturers
- 3.1.3 Global Cryptococcosis Market Concentration Ratio (CR5 and HHI)
- 3.2 Cryptococcosis Revenue by Manufacturers
- 3.2.1 Cryptococcosis Revenue by Manufacturers (2014-2019)
- 3.2.2 Cryptococcosis Revenue Share by Manufacturers (2014-2019)
- 3.3 Cryptococcosis Price by Manufacturers
- 3.4 Cryptococcosis Manufacturing Base Distribution, Product Types
- 3.4.1 Cryptococcosis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cryptococcosis Product Type
- 3.4.3 Date of International Manufacturers Enter into Cryptococcosis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cryptococcosis Sales by Product
- 4.2 Global Cryptococcosis Revenue by Product
- 4.3 Cryptococcosis Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cryptococcosis Breakdown Data by End User
6 North America
- 6.1 North America Cryptococcosis by Countries
- 6.1.1 North America Cryptococcosis Sales by Countries
- 6.1.2 North America Cryptococcosis Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cryptococcosis by Product
- 6.3 North America Cryptococcosis by End User
7 Europe
- 7.1 Europe Cryptococcosis by Countries
- 7.1.1 Europe Cryptococcosis Sales by Countries
- 7.1.2 Europe Cryptococcosis Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cryptococcosis by Product
- 7.3 Europe Cryptococcosis by End User
8 Asia Pacific
- 8.1 Asia Pacific Cryptococcosis by Countries
- 8.1.1 Asia Pacific Cryptococcosis Sales by Countries
- 8.1.2 Asia Pacific Cryptococcosis Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cryptococcosis by Product
- 8.3 Asia Pacific Cryptococcosis by End User
9 Central & South America
- 9.1 Central & South America Cryptococcosis by Countries
- 9.1.1 Central & South America Cryptococcosis Sales by Countries
- 9.1.2 Central & South America Cryptococcosis Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cryptococcosis by Product
- 9.3 Central & South America Cryptococcosis by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cryptococcosis by Countries
- 10.1.1 Middle East and Africa Cryptococcosis Sales by Countries
- 10.1.2 Middle East and Africa Cryptococcosis Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cryptococcosis by Product
- 10.3 Middle East and Africa Cryptococcosis by End User
11 Company Profiles
- 11.1 Bristol-Myers Squibb
- 11.1.1 Bristol-Myers Squibb Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bristol-Myers Squibb Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bristol-Myers Squibb Cryptococcosis Products Offered
- 11.1.5 Bristol-Myers Squibb Recent Development
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Johnson & Johnson Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Johnson & Johnson Cryptococcosis Products Offered
- 11.2.5 Johnson & Johnson Recent Development
- 11.3 Abbott
- 11.3.1 Abbott Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Abbott Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Abbott Cryptococcosis Products Offered
- 11.3.5 Abbott Recent Development
- 11.4 Novartis
- 11.4.1 Novartis Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Novartis Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Novartis Cryptococcosis Products Offered
- 11.4.5 Novartis Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pfizer Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pfizer Cryptococcosis Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 Valeant Pharmaceuticals
- 11.6.1 Valeant Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Valeant Pharmaceuticals Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Valeant Pharmaceuticals Cryptococcosis Products Offered
- 11.6.5 Valeant Pharmaceuticals Recent Development
- 11.7 Glenmark
- 11.7.1 Glenmark Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Glenmark Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Glenmark Cryptococcosis Products Offered
- 11.7.5 Glenmark Recent Development
- 11.8 Viamet Pharmaceuticals
- 11.8.1 Viamet Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Viamet Pharmaceuticals Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Viamet Pharmaceuticals Cryptococcosis Products Offered
- 11.8.5 Viamet Pharmaceuticals Recent Development
- 11.9 Sigmapharm
- 11.9.1 Sigmapharm Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sigmapharm Cryptococcosis Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sigmapharm Cryptococcosis Products Offered
- 11.9.5 Sigmapharm Recent Development
12 Future Forecast
- 12.1 Cryptococcosis Market Forecast by Regions
- 12.1.1 Global Cryptococcosis Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cryptococcosis Revenue Forecast by Regions 2019-2025
- 12.2 Cryptococcosis Market Forecast by Product
- 12.2.1 Global Cryptococcosis Sales Forecast by Product 2019-2025
- 12.2.2 Global Cryptococcosis Revenue Forecast by Product 2019-2025
- 12.3 Cryptococcosis Market Forecast by End User
- 12.4 North America Cryptococcosis Forecast
- 12.5 Europe Cryptococcosis Forecast
- 12.6 Asia Pacific Cryptococcosis Forecast
- 12.7 Central & South America Cryptococcosis Forecast
- 12.8 Middle East and Africa Cryptococcosis Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cryptococcosis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cryptococcosis. Industry analysis & Market Report on Cryptococcosis is a syndicated market report, published as Global Cryptococcosis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cryptococcosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
